Neuronet publishes series of project introduction videos during Brain Awareness Week
The Neuronet programme launched a series of short introduction videos of the various Innovative Medicines
AETIONOMY
Study finds that Kininogen-1 levels in CSF may serve as a marker of cognitive impairment in Parkinson’s disease
Cognitive impairment is common in patients with Parkinson’s disease (PD). Core markers of Alzheimer’s dementia
Overcoming data “silos” to accelerate the overall scientific progress in translational research
Translational research of many disease areas requires a longitudinal understanding of disease development and progression
Neuronet launches its social media campaign “Programme impact analysis – where we are and where we need to go”
The Neuronet project is setting up an efficient platform to boost collaboration across research projects
Neuronet convenes 7th meeting of its Scientific Coordination Board
On 21 October, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened
1st Fraunhofer Symposium on the “Human Brain PHARMACOME”
The neurodegeneration research community remembers the major outcome of the AETIONOMY project funded by the
Spotlight on early-career researchers: a Neuronet interview with Colin Birkenbihl
In this Neuronet interview, we speak to Colin Birkenbihl, a doctoral candidate at the Fraunhofer
Neuronet convenes 6th meeting of its Scientific Coordination Board
On 22 March, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened
Alzheimer Europe sets out recommendations to improve data sharing in dementia research
Luxembourg, 23 February 2021 – At an online European Parliament workshop hosted by Deirdre Clune
Neuronet Working Group on sustainability holds an online meeting, sharing sustainability plans among projects
On 25 January, Neuronet hosted an online meeting of its WG on Sustainability, moderated by